SCHEMBL6419829

SCHEMBL6419829

CC(O)CCc1cc(C(C)C)c(O)c(C(C)C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.53
GABRA1 P14867 5/20 0.51
GABRB1 P18505 5/20 0.51
GABRB2 P47870 3/20 0.51
GABRA5 P31644 2/20 0.51
GABRA3 P34903 2/20 0.51
GABRA2 P47869 2/20 0.51
GABRA4 P48169 2/20 0.51
GABRA6 Q16445 2/20 0.51
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
TRPA1 O75762 1/20 0.46
MAPT P10636 1/20 0.44
TYR P14679 2/20 0.42
FAAH O00519 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10630163 0.81 GSR (0.50) GSRGABRA1GABRB1GABRB2GABRA5
SCHEMBL6414244 0.79 TYR (0.46) CA1CA2MAPTTYRLMNA
SCHEMBL13057520 0.79 GSR (0.57) GSRGABRA1GABRB1GABRB2GABRA5
SCHEMBL11578331 0.78 GSR (0.47) GSRGABRA1GABRB1GABRB2GABRA5
SCHEMBL4594369 0.78 GSR (0.55) GSRGABRA1GABRB1GABRB2GABRA5
SCHEMBL4595014 0.78 GSR (0.55) GSRGABRA1GABRB1GABRB2GABRA5
SCHEMBL27928023 0.78 PTGS1 (0.48) CA1CA2MAPTTYRLMNA
SCHEMBL2467528 0.76 GSR (0.63) GSRGABRA1GABRB1GABRB2GABRA5
SCHEMBL200138 0.76 GABRA1 (0.60) GSRGABRA1GABRB1GABRB2GABRA5
SCHEMBL11810825 0.76 GSR (0.53) GSRGABRA1GABRB1GABRB2GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050277700-A1 Non-halogenated hydroxyalkyl-substituted phenol compounds, antimicrobial compositions containing the same, and methods of using the same MCNEIL-PPC, INC 2005-12-15 US disclosed
US-20040199028-A1 Non-halogenated hydroxyalkyl-substituted phenol compounds, antimicrobial compositions containing the same, and methods of using the same MCNEIL-PPC, INC 2004-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277700-A1 Non-halogenated hydroxyalkyl-substituted phenol compounds, antimicrobial compositions containing the same, and methods of using the same HDHD5, TYR, NONO GSR 1658/4885GABRA1 4282/4885GABRB1 4487/4885
US-20040199028-A1 Non-halogenated hydroxyalkyl-substituted phenol compounds, antimicrobial compositions containing the same, and methods of using the same HDHD5, TYR, NONO GSR 1658/4885GABRA1 4282/4885GABRB1 4487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.